Plasma Technology For Inflammation & Degeneration of Joints in Horses

Introducing

Alpha2EQ® and Alpha2CP®

Science is the driving force behind everything we do. Astaria’s AlphaActive™ is a highly improved process leveraging PRP methodology derivative of Platelet Poor Plasma (PPP) that concentrates plasma proteins from the equine patient’s own blood. This patented process is what is inside our therapies. Alpha2EQ and Alpha2CP are the orthobiologic devices that isolate and concentrate Alpha-2 Macroglobulin (α2M), the active molecule.

The World's α2M Concentrate Therapy

The AlphaActive process isolates the α2M molecule, which is a powerful inhibitor of cartilage catabolic factors and slows the progression of osteoarthritis by preventing cartilage breakdown and loss.
  • The α2M molecule has proven success in decreasing inflammation, relieving pain and modulating cartilage degeneration that is the result of osteoarthritis.
  • With our therapies, veterinarians can process and treat in just one hour with an uncomplicated three-step, minimally invasive procedure.
  • The multi-dose kit allows veterinarians to inject multiple sites in the same treatment.
  • Alpha2EQ provides the highest level of concentration of α2M in plasma available on the market today — up to five times more than naturally occurring levels.
  • 100% drug free and has no competition restrictions. It has no banned substances. Always follow your organization’s rules for general joint injections.

The AlphaActive (α2M ) Concentrate Delivers Proven Results

α2M is a large glycoprotein, which is part of the innate immune system

α2M is naturally present in the joints of many species, including dogs and horses

Our therapies are powered by the advanced, patented AlphaActive Concentrate Process

Only orthobiologic device proven to isolate and concentrate α2M from plasma, intensifying the all-natural healing proteins of the blood